Shilajit for Real Performance: The “Strength-Under-Fatigue” Study

In this Energy Code Deep Dive episode, Dr. Mike breaks down a practical 8-week human study on shilajit and performance where it actually matters: after fatigue sets in. Recreationally active young men took placebo, 250 mg/day, or 500 mg/day, then got pushed through a brutal leg-extension fatigue protocol to see how much strength they lost — not just how strong they were fresh. The standout finding: in the stronger half of subjects, the 500 mg group preserved significantly more maximal isometric strength post-fatigue — and showed a quieter signal on serum hydroxyproline, a marker often used to reflect collagen/connective-tissue turnover. Bottom line: this paper doesn’t claim “instant strength.” It suggests shilajit may be more interesting as a fatigue-resistance + tissue-support tool — at the right dose, in the right population. (Educational content only, not medical advice.) - Article Discussed in Episode: The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels - Key Quotes From Dr. Mike: “In that stronger subgroup, the high dose shilait group lost significantly less maximal isometric strength after the fatiguing protocol…” “So in simple terms, the men taking 500 mg per day of Sheelajit held on to their strength better once fatigue hit.” “This was not a study showing Shilait magically blocks exercise damage… It is more a study suggesting that over time, the higher dose may support the tissue environment…” “The strongest and cleanest finding is this… 500 mg per day… helped preserve maximal strength better after fatigue…” “Sometimes performance support is not about creating more force at the start. Sometimes it is about losing less force when fatigue tries to take it away.” - Key Points The study asks a real-world question: how much strength do you lose when you’re tired? Design: recreationally active young men; placebo vs 250 mg/day vs 500 mg/day for 8 weeks. Test: maximal isometric strength pre-fatigue, then 2×50 maximal concentric isokinetic leg extensions, then post-fatigue testing. Primary performance signal showed up in the upper 50% (stronger subjects): 500 mg/day = less post-fatigue strength loss. The lower dose (250 mg/day) did not clearly separate from placebo in that stronger subgroup. Hydroxyproline (HYP) was used as an indirect marker of collagen/connective-tissue breakdown. In the stronger subgroup, the 500 mg/day group had lower baseline HYP vs low dose and placebo after supplementation. No big claims of “massive strength gain,” “weight change,” or “muscle growth.” The story is fatigue-retention, not “overnight PRs.” Mechanistic framing is suggestive (ATP/mitochondrial support is discussed), but the study itself is performance + serum marker, not deep mitochondrial assays. Limitations: young men only, specific fatigue model (concentric-dominant), and funding/source considerations. - Episode timeline 0:19–0:34 — Show open + setup for a shilajit performance Deep Dive 0:34–1:30 — The question: 8 weeks of shilajit—does it help strength retention under fatigue + connective tissue signals? 1:38–2:14 — What shilajit is (Ayurvedic mineral-rich exudate; fulvic acids, DBPs, minerals) 2:14–2:58 — Study design: placebo vs 250 mg/day vs 500 mg/day; 8-week supplementation 2:40–3:22 — The fatigue protocol + why “strength loss under fatigue” is the real-world metric 3:27–4:14 — Hydroxyproline explained as a collagen/connective-tissue breakdown signal 4:15–5:01 — Main finding: overall modest, but stronger subgroup shows a clearer effect 4:29–5:36 — Headline: 500 mg/day group lost less maximal isometric strength post-fatigue (in stronger half) 5:36–6:09 — Dose specificity: 250 mg/day didn’t separate clearly; possible threshold effect at 500 mg 6:13–7:38 — Hydroxyproline results + why the concentric-only protocol matters for interpretation 7:59–9:04 — Mechanistic framing (ATP/mitochondria discussion as a plausible lens) 9:04–10:31 — What the study did no